Senti Biosciences (SNTI) Announces 1-for-10 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Senti Bio Announces Reverse Stock Split
July 16, 2024 8:30 AM EDTShares expected to begin trading on split-adjusted basis on July 18, 2024
SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (Senti Bio) , a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that its Board of Directors has determined to effect a one-for-ten (1-for-10) reverse stock split of Senti Bios common stock, par value $0.0001 per share (the Common Stock).
The reverse stock split will take effect at 11:59 p.m. EDT on July 17, 2024, and Senti Bios common... More
